TrialEuropean journal of haematology2010

First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.

Thomas Lund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.